Photo from Mark Wildgust / Twitter
Aug 13, 2023, 09:17
TALVEY (Talquetamab) is now FDA approved – Mark Wildgust
In a tweet by Mark Wildgust, Vice President of Oncology Global Medical Affairs at Janssen, J&J, it is mentioned, “TALVEY (Talquetamab) is now FDA approved. Thank you to all the patients, families, investigators and Janssen Global team who worked so hard to make this possible. MonumenTAL!”
For details click here
Source: Mark Wildgust / Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 15, 2025, 16:20
Jan 15, 2025, 16:16
Jan 15, 2025, 16:16
Jan 15, 2025, 16:13
Jan 15, 2025, 16:11
Jan 15, 2025, 15:57
Jan 15, 2025, 15:20
Jan 15, 2025, 15:18